项目

血细胞成分

治疗前组

治疗后组

N

( X ¯ ± S D )

N

( X ¯ ± S D )

WBC (109/L)

15

12.84 ± 3.64a

15

13.06 ± 4.49a

LYM (%)

15

40.62 ± 11.94a

15

46.45 ± 14.42a

MID (%)

15

15.30 ± 3.21a

15

12.46 ± 3.90b

GRAN (%)

15

42.04 ± 7.51a

15

61.76 ± 76.75a

LYM (109/L)

15

5.59 ± 2.15a

15

5.85 ± 2.59a

MID (109/L)

15

2.02 ± 0.74a

15

1.56 ± 0.52a

GRAN (109/L)

15

5.23 ± 1.29a

15

5.58 ± 3.78a

RBC (1012/L)

15

4.89 ± 0.83a

15

5.47 ± 0.87a

HGB (g/L)

15

109.40 ± 22.73a

15

109.27 ± 16.31a

HCT (%)

15

24.10 ± 4.41a

15

28.33 ± 6.34b

MCV (fL)

15

49.23 ± 0.87a

15

50.59 ± 2.11b

MCH (pg)

15

22.17 ± 2.86a

15

20.04 ± 1.82b

MCHC (g/L)

15

461.20 ± 63.05a

15

398.80 ± 46.99b

RDW-SD (fL)

15

18.83 ± 1.18a

15

20.19 ± 2.08a

RDW-CV (%)

15

12.49 ± 0.68a

15

13.08 ± 0.96a